{"nct_id":"NCT06517485","title":"First-in-Human Dose Expansion Study of XMT-1536 in Cancers Likely to Express NaPi2b","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2019-07-30","start_date_type":"ACTUAL","primary_completion_date":"2022-05-31","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRSN"]}